Publications by authors named "C-Y O Chen"

Objective: We evaluated the cost-effectiveness of a bundled intervention including an antimicrobial stewardship program (ASP), procalcitonin (PCT) testing, and rapid blood culture identification (BCID), compared with pre-implementation standard care in critically ill adult patients with sepsis.

Methods: We conducted a decision tree model-based cost-effectiveness analysis alongside a previously published pre- and post-implementation quality improvement study. We adopted a public Canadian healthcare payer's perspective.

View Article and Find Full Text PDF

Sequential adaptive trial designs can help accomplish the goals of personalized medicine, optimizing outcomes and avoiding unnecessary toxicity. Here we describe the results of incorporating a promising antibody-drug conjugate, datopotamab-deruxtecan (Dato-DXd) in combination with programmed cell death-ligand 1 inhibitor, durvalumab, as the first sequence of therapy in the I-SPY2.2 phase 2 neoadjuvant sequential multiple assignment randomization trial for high-risk stage 2/3 breast cancer.

View Article and Find Full Text PDF

Sustainable CO conversion is crucial in curbing excess emissions. Molybdenum carbide catalysts have demonstrated excellent performances for catalytic CO conversion, but harsh carburization syntheses and poor stabilities make studies challenging. Here an unsaturated Mo oxide (MoO) shows a high activity for the reverse water-gas shift reaction, without carburization pretreatments, and remains stable for 2,000 h at 600 °C.

View Article and Find Full Text PDF
Article Synopsis
  • Dehydrocorydaline (DHC), an active component of a plant used in traditional medicine, shows promise in treating coronary heart disease due to its protective and pain-relieving effects, though the mechanism is not fully understood.
  • The study aimed to investigate whether DHC can mitigate myocardial ischemia-reperfusion injury (MIRI) by affecting the FoxO signaling pathway to reduce cell death (apoptosis).
  • Experimental results demonstrated that DHC improved heart function in a mouse model of MIRI and reduced apoptosis and oxidative stress in heart cells exposed to hypoxia, principally through the FoxO pathway.
View Article and Find Full Text PDF

To meet the demand for quillaic acid, a multigram synthesis of quillaic acid was accomplished in 14 steps, starting from oleanolic acid, leading to an overall yield of 3.4%. Key features include C-H activation at C-16 and C-23.

View Article and Find Full Text PDF

Background: Adult mammalian cardiomyocytes have limited proliferative capacity, but in specifically induced contexts they traverse through cell-cycle reentry, offering the potential for heart regeneration. Endogenous cardiomyocyte proliferation is preceded by cardiomyocyte dedifferentiation (CMDD), wherein adult cardiomyocytes revert to a less matured state that is distinct from the classical myocardial fetal stress gene response associated with heart failure. However, very little is known about CMDD as a defined cardiomyocyte cell state in transition.

View Article and Find Full Text PDF

Evidence is accumulating that perturbed postnatal development of the gut microbiome contributes to childhood malnutrition. Here we analyse biospecimens from a randomized, controlled trial of a microbiome-directed complementary food (MDCF-2) that produced superior rates of weight gain compared with a calorically more dense conventional ready-to-use supplementary food in 12-18-month-old Bangladeshi children with moderate acute malnutrition. We reconstructed 1,000 bacterial genomes (metagenome-assembled genomes (MAGs)) from the faecal microbiomes of trial participants, identified 75 MAGs of which the abundances were positively associated with ponderal growth (change in weight-for-length Z score (WLZ)), characterized changes in MAG gene expression as a function of treatment type and WLZ response, and quantified carbohydrate structures in MDCF-2 and faeces.

View Article and Find Full Text PDF

Background: High circulating levels of Lp(a) (lipoprotein[a]) increase the risk of atherosclerosis and calcific aortic valve disease, affecting millions of patients worldwide. Although atherosclerosis is commonly treated with low-density lipoprotein-targeting therapies, these do not reduce Lp(a) or risk of calcific aortic valve disease, which has no available drug therapies. Targeting Lp(a) production and catabolism may provide therapeutic benefit, but little is known about Lp(a) cellular uptake.

View Article and Find Full Text PDF
Article Synopsis
  • Transthyretin amyloidosis (ATTR) leads to amyloid deposits in the heart, resulting in progressive cardiomyopathy, and patisiran has been developed to reduce the production of transthyretin in the liver.
  • In a phase 3 trial, 360 patients with hereditary or wild-type ATTR cardiac amyloidosis received either patisiran or a placebo for 12 months, with various health metrics being assessed.
  • Results showed that patients receiving patisiran experienced less decline in the 6-minute walk test and improved health scores compared to the placebo group, although benefits for some secondary outcomes were not significant and adverse reactions were noted.
View Article and Find Full Text PDF

The bridging attraction of condensed bovine serum albumin (BSA) solution (DO) in the presence of yttrium chloride (YCl) was studied by small angle neutron scattering (SANS). With increasing the concentration of YCl (c) from 3 to 15 mM and from 15 to 100 mM, the intensity in low-q region increases and then decreases. Combining the tri-axial ellipsoid (TaE) geometry and the multi-component sticky hard sphere (SHS) potential, a SHS-TaE model was established to quantitatively determine the size and distribution of particles.

View Article and Find Full Text PDF
Article Synopsis
  • The study assessed a deep learning model's ability to distinguish between malignant and benign breast tumors using ultrasound images from multiple hospitals.
  • It involved 45,909 images and included interpretations from both novice and experienced radiologists to evaluate the model's impact on diagnosis accuracy.
  • The findings showed high diagnostic performance with AUC scores around 0.94 and suggested that the model can enhance the accuracy and consistency of radiologists, particularly those with less experience.
View Article and Find Full Text PDF
Article Synopsis
  • The Pharma Proteomics Project is a large-scale research initiative analyzing blood protein profiles from over 54,000 UK Biobank participants to understand links between genetics and health.
  • The project identifies significant genetic associations with proteins, revealing many novel interactions and highlighting ancestry-specific variations, along with insights into disease mechanisms and potential drug targets.
  • By making their findings publicly accessible, the consortium aims to advance research in biomarker development and therapeutic strategies, enhancing our understanding of how genetic factors influence health outcomes.
View Article and Find Full Text PDF

Pegozafermin (also known as BIO89-100) is a glycoPEGylated analog of fibroblast growth factor 21 (FGF21) under development to treat nonalcoholic steatohepatitis (NASH) and severe hypertriglyceridemia (SHTG). In cell-based assays, pegozafermin had a similar receptor engagement profile as recombinant FGF21, with approximately eightfold higher potency at fibroblast growth factor receptor 1c (FGFR1c). In diabetic monkeys, once-weekly and once-every-2-weeks regimens of subcutaneous pegozafermin provided rapid and robust benefits for an array of metabolic biomarkers, including triglycerides, cholesterol, fasting glucose, glycated hemoglobin, adiponectin, alanine aminotransferase, food intake, and body weight.

View Article and Find Full Text PDF

KAT6A, and its paralog KAT6B, are histone lysine acetyltransferases (HAT) that acetylate histone H3K23 and exert an oncogenic role in several tumor types including breast cancer where KAT6A is frequently amplified/overexpressed. However, pharmacologic targeting of KAT6A to achieve therapeutic benefit has been a challenge. Here we describe identification of a highly potent, selective, and orally bioavailable KAT6A/KAT6B inhibitor CTx-648 (PF-9363), derived from a benzisoxazole series, which demonstrates anti-tumor activity in correlation with H3K23Ac inhibition in KAT6A over-expressing breast cancer.

View Article and Find Full Text PDF

Purpose: To evaluate the functional and structural changes of the meibomian glands and ocular surface in immunoglobulin G4-related ophthalmic disease (IgG4-ROD) patients.

Design: Cross-sectional, matched case-control comparison study.

Methods: This study included 64 patients with biopsy-proven IgG4-ROD (aged 63.

View Article and Find Full Text PDF

Background: Spinal cord stimulation (SCS) has been investigated as a potential therapeutic option for managing refractory symptoms in patients with Parkinson's disease (PD).

Objective: This systematic review and meta-analysis aimed to evaluate the safety and efficacy of SCS in PD.

Method: A comprehensive literature search was conducted on PubMed and Web of Science to identify SCS studies reporting Unified Parkinson Disease Rating Scale-III (UPDRS-III) or Visual Analogue Scale (VAS) score changes in PD cohorts with at least 3 patients and a follow-up period of at least 1 month.

View Article and Find Full Text PDF

In this work, high-performance two-dimensional (2D) graphene-based single-atom electrocatalysts (ZZ/ZA-MNC) for the oxygen reduction reaction (ORR) were screened out using machine learning (ML). A model was built for the fast prediction of electrocatalysts and two descriptors valence electron correction (VEc) and degree of construction differences (DC) were proposed to improve the accuracy of the model prediction. Two evaluation criteria, high-performance catalyst retention rate and high-performance catalyst occupancy rate , were proposed to evaluate the accuracy of ML models in high-performance catalyst screening.

View Article and Find Full Text PDF

Background: Anti-β2GP1 (β2-glycoprotein 1) antibodies are the primary pathogenic antibody to promote thrombosis in antiphospholipid syndrome (APS), yet the underlying mechanism remains obscure. We aimed to explore the intracellular pathway that mediated platelet activation.

Methods: Platelets were isolated from patients with APS and subjected to RNA sequencing.

View Article and Find Full Text PDF

Carbon supports containing single-atomically dispersed metal-N (denoted as M-NC, , : coordination number) have attracted increasing attention due to their superb performance in heterogeneous catalysis. However, large-scale controllable preparation of single-atom catalysts (SACs) with high concentration of supported metal-N is still a big challenge because of the metal atom agglomeration during synthesis at high density and temperatures. Herein, we report a stepwise anchoring strategy from a 1,10--phenanthroline Pt chelate to an N-doped carbon (NC) with isolated Pt single-atom catalysts (Pt-NC) containing Pt loadings up to 5.

View Article and Find Full Text PDF

Aiming to improve the environmental stability of organic photovoltaics, a multilayered SiO C /a-SiN (O):H composite barrier film coated with a hydrophobic perfluoro copolymer stop layer for polymer:non-fullerene solar cells is developed. The composite film is prepared by spin-coating of polysilicone and perhydropolysilazane (PHPS) following a densification process by vacuum ultraviolet irradiation in an inert atmosphere. The transformation of polysilicone and PHPS to SiO C and a-SiN (O):H is confirmed by Fourier transform infrared and energy-dispersive X-ray spectroscopy measurement.

View Article and Find Full Text PDF

Identification of therapeutic targets from genome-wide association studies (GWAS) requires insights into downstream functional consequences. We harmonized 8,613 RNA-sequencing samples from 14 brain datasets to create the MetaBrain resource and performed cis- and trans-expression quantitative trait locus (eQTL) meta-analyses in multiple brain region- and ancestry-specific datasets (n ≤ 2,759). Many of the 16,169 cortex cis-eQTLs were tissue-dependent when compared with blood cis-eQTLs.

View Article and Find Full Text PDF
Article Synopsis
  • Population isolates like Finland provide a unique advantage for genetic research by having concentrated deleterious alleles in low-frequency variants due to historical bottlenecks.
  • The FinnGen study aims to analyze data from 500,000 Finnish individuals, focusing on their genomes and health records, particularly as many participants are older and have disease-related data.
  • From the analysis of 224,737 participants and additional biobank data, researchers discovered 30 new associations and a total of 2,733 significant genetic links across various diseases, highlighting the importance of low-frequency variants in understanding common diseases.
View Article and Find Full Text PDF

Purpose: We previously reported miR-328-3p as a novel risk factor for myopia through a genetic association study of the PAX6 gene. In the present study, we first explored the effects of miR-328-3p on other myopia-related genes, and then tested whether anti-miR-328-3p may be used for myopia control.

Methods: The luciferase report assay and transient transfection were used to confirm miR-328-3p target genes.

View Article and Find Full Text PDF

Background And Objectives: Declines in stroke admission, IV thrombolysis (IVT), and mechanical thrombectomy volumes were reported during the first wave of the COVID-19 pandemic. There is a paucity of data on the longer-term effect of the pandemic on stroke volumes over the course of a year and through the second wave of the pandemic. We sought to measure the effect of the COVID-19 pandemic on the volumes of stroke admissions, intracranial hemorrhage (ICH), IVT, and mechanical thrombectomy over a 1-year period at the onset of the pandemic (March 1, 2020, to February 28, 2021) compared with the immediately preceding year (March 1, 2019, to February 29, 2020).

View Article and Find Full Text PDF

Previous genome-wide association studies (GWASs) of stroke - the second leading cause of death worldwide - were conducted predominantly in populations of European ancestry. Here, in cross-ancestry GWAS meta-analyses of 110,182 patients who have had a stroke (five ancestries, 33% non-European) and 1,503,898 control individuals, we identify association signals for stroke and its subtypes at 89 (61 new) independent loci: 60 in primary inverse-variance-weighted analyses and 29 in secondary meta-regression and multitrait analyses. On the basis of internal cross-ancestry validation and an independent follow-up in 89,084 additional cases of stroke (30% non-European) and 1,013,843 control individuals, 87% of the primary stroke risk loci and 60% of the secondary stroke risk loci were replicated (P < 0.

View Article and Find Full Text PDF